A Randomised Placebo Controlled Double Blinded Study Of Oral Zinc supplementation in Preterm Neonates with Indirect Hyperbilirubinemia

PRETERM NEONATS WITH INDIRECTHYPERBILIRUBINEMIA AFTER APPLYING INCLUSIO AND EXCLUSION CRITERIA ARE RANDOMLY ASSIGNED TO 2 GROUPS ONE IS INTERVENTIONAL AND OTHER IS PLACEBO GROUP AND GIVE ORAL SYRUP ZINC SULPHATE OR NORMAL SALINE 0.5ML TWICE DAILY UNTIL BILIRUBIN FALLS BELOW PHOTO THERAPY RANGE AND MEASURE TOTAL AND INDIRECT BILIRUBIN LEVELS BETWEEN TWO GROUPS AT 24 HOURS AND 48 HOURS OF INTERVENTION